90382 Rsv monoc antb seasn .7ml intramuscular
Medicine
Also known as: RSV mAb 0.7ml, palivizumab mid-dose, RSV prophylaxis
Respiratory syncytial virus monoclonal antibody for seasonal prophylaxis administered intramuscularly in 0.7 milliliter dose.
Clinical Context
Monthly intramuscular monoclonal antibody in 0.7 milliliter dose for standard prophylaxis of high-risk pediatric patients during respiratory syncytial virus season.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.